Aagami has been appointed for BD support, by an independent global Contract Research Organization (CRO) offering comprehensive non clinical GLP r...
Published : 01 Nov 2016
Read MoreA UK based pharma company has appointed Aagami to look for strategic partnership relating to their branded generics laxative for treatment of chronic ...
Published : 01 Nov 2016
Read MoreA US biotechnology-based pharmaceutical company focused on the development and commercialization of novel cancer therapies has appointed Aagami to see...
Published : 21 Oct 2016
Read MoreAagami CEO Dinesh Jain will visit Seoul in South Korea in December 2016, to attend the Korea Drug Development Fund Techfair 2016. He is a key speaker ...
Published : 21 Oct 2016
Read MoreA Canada based past client of Aagami, has appointed Aagami for seeking licensing/do-development partnerships for their Phase 3 chemotherapy candidate,...
Published : 23 Sep 2016
Read MoreIt gives us immense pleasure to announce that Linda Pullan has joined Aagami Inc. as a partner Consultant. We see it as a major development which will...
Published : 28 Jul 2016
Read MoreIndia's fast-growing BioEconomy has crossed the $35.1 billion in 2015, according to a Special Report prepared by the Association of Biotechnology-Led ...
Published : 08 Jun 2016
Read MoreAagami CEO Dinesh Jain, and President Shubhra Jain are participating in the 2016 BIO International Convention which will be held next week (6-9) in Sa...
Published : 05 Jun 2016
Read MoreAfter organising a conference at Illinois Science and Technology Park on June 2, Aagami CEO attended the French/American Partnering Day – Oncology, ...
Published : 04 Jun 2016
Read MoreAagami Inc. and Rosen Biosciences is organising an event on 02 June at the Illinois Science + Technology Park, Skokie, Illionois. This event will...
Published : 18 May 2016
Read More